$SDGR News
Last published 1d ago
- 1d agoSDGRUBS Global Healthcare Conference - SCHRODINGER INCEarnings Call TranscriptsGood morning, everybody. Welcome to day two of the UBS Healthcare Conference. I'm Kevin Caliendo, UBS healthcare IT and distribution analyst, and we are very proud and happy to have with us today, management team from Sc
- 1w agoSDGRSchrodinger, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
- 2w agoSDGRSchrödinger to Present at UBS Global Healthcare ConferenceBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in a fireside chat at the UBS Global Healthcare Conference. The live presentation will take place on Tuesday, November 10, 2026 at 9:30
- 2w agoSDGRSchrödinger Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on October 21, 2026, the company granted restricted stock units (RSUs) with respect to 5,716 shares of the company’s common stock to five newly hired employees. These
- 3w agoSDGRSchrödinger to Announce Third Quarter 2026 Financial Results on November 4Business WireSchrödinger, Inc. (NASDAQ:SDGR) will report its third quarter 2026 financial results on Wednesday, November 4, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m.
- 4w agoSDGRSchrödinger Research Published in Nature Reveals New Insights into Lithium-Ion Battery ChemistryBusiness WireNew study uncovers multi-lithium ion clustering in common battery electrolytes, paving the way for improved battery performance and design Schrödinger, Inc. (NASDAQ:SDGR) today announced the publication of new
- 1mo agoSDGRSchrodinger - Morgan Stanley 24th Annual Global Healthcare Conference - SCHRODINGER INCEarnings Call TranscriptsSorry, Richie. Great. Well, welcome. Good afternoon, everyone. It's the first day of the conference here. I'm Craig Kettenbach. I cover healthcare technology and providers with Morgan Stanley. Very pleased to have with u
- 2mo agoSDGRSchrödinger Announces Licensing and Collaboration Agreement with Tectora Therapeutics, a New Biotechnology Company It Co-founded to Advance Immunology and Inflammation ProgramsBusiness WireTectora secures $55 million Series A investment from NEA and RA Capital Management Schrödinger, Inc. (NASDAQ:SDGR) today announced the formation of Tectora, a new biotechnology company it co-founded with New
- 2mo agoHYFTTEMSDGRTWST+1AI in Drug Discovery Market Projected to Reach $8.52 Billion By 2030PR NewswireEquity Insider News Commentary - Pharmaceutical research is being rebuilt around artificial intelligence faster than the industry can absorb it....
- 2mo agoSDGRSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference. The live presentation will take place on Monday,
- 2mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on August 12, 2026, the company granted restricted stock units (RSUs) with respect to 3,315 shares of the company’s common stock to two newly hired employees. These
- 3mo agoHYFTTEMSDGRABCL+1AI Found an Influenza Target That Survives Viral MutationGlobeNewswireAUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Equity Insider News Commentary - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and
- 3mo agoSDGRSchrödinger Reports Second Quarter 2026 Financial ResultsBusiness WireSecond Quarter ACV of $30 Million, Representing 27% Growth Launched Early Access Version of Bunsen, A New Agentic AI Co-Scientist for Molecular Discovery Schrödinger, Inc. (NASDAQ:SDGR) today announced financial
- 3mo agoSDGRSchrödinger Announces Strategic Collaboration and Software Agreement with Bristol Myers Squibb to Deploy AI Co-Scientist Bunsen for Agentic Drug DiscoveryBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced a strategic agreement with Bristol Myers Squibb (BMS) to deploy Bunsen, Schrödinger's agentic AI co-scientist, within its research organization. Building on a
- 3mo agoSDGRSchrödinger Introduces Bunsen, an AI Co-Scientist for Molecular DiscoveryBusiness WireCollaboration with NVIDIA and Google Cloud Provide Additional Tools and Compute Access Schrödinger, Inc. (NASDAQ:SDGR) today announced the launch of its early access version of Bunsen, its new agentic AI co-scientist
- 3mo agoHYFTSDGRABCLRLAY+1An AI Biotech Just Reported a 46% Revenue Jump and Its First Recurring Platform Contracts, as Its Pivot Starts Showing Up in the NumbersPR NewswireFor years, the promise of artificial intelligence in drug discovery has been easy to describe and hard to monetize. Plenty of companies can talk...
- 3mo agoSDGRSchrödinger to Announce Second Quarter 2026 Financial Results on August 5Business WireSchrödinger, Inc. (NASDAQ:SDGR) will report its second quarter 2026 financial results on Wednesday, August 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m.
- 3mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on July 16, 2026, the company granted restricted stock units (RSUs) with respect to 3,691 shares of the company’s common stock to four newly hired employees. These
- 4mo agoHYFTTEMABCLSDGR+1As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the DataPR NewswireUSA News Group, There is a growing consensus in artificial intelligence that the models themselves are becoming interchangeable, and that lasting...
- 4mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on June 12, 2026, the company granted restricted stock units (RSUs) with respect to 10,771 shares of the company's common stock to seven newly hired employees. These
- 4mo agoHYFTABSIRXRXSDGR+1The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath ItPR NewswireEquity Insider News Commentary — The story the market has been telling itself about artificial intelligence and drug discovery is, at its core, a...
- 5mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on May 18, 2026, the company granted (i) a non-statutory stock option to purchase 1,875 shares of the company's common stock to one newly hired employee and (ii)
- 6mo agoSDGRSchrödinger Reports First Quarter 2026 Financial ResultsBusiness WireFirst Quarter ACV of $28 Million, Representing 12% Growth Continued Momentum in Transition to Hosted Software Licensing Schrödinger to Launch Bunsen, an Agentic AI Co-Scientist, This Summer Lilly's Announced $2.3
- 6mo agoSDGRSchrödinger to Participate in Upcoming Investor ConferencesBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in the following conferences in May: BofA Securities 2026 Healthcare Conference: Fireside chat on Wednesday, May 13, 2026, at 5:20 p.m.
- 6mo agoSDGRSchrödinger to Announce First Quarter 2026 Financial Results on May 5Business WireSchrödinger, Inc. (NASDAQ:SDGR) will report its first quarter 2026 financial results on Tuesday, May 5, 2026, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The
- 6mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on April 16, 2026, the company granted restricted stock units (RSUs) with respect to 4,253 shares of the company's common stock to four newly hired employees. These
- 7mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on March 14, 2026, the company granted (i) a non-statutory stock option to purchase 1,950 shares of the company's common stock to one newly hired employee and (ii)
- 8mo agoSDGRSchrödinger Fourth Quarter and Full-Year 2025 Financial Results Conference CallSCHRODINGER INCEarnings Call TranscriptsThank you for standing by. Welcome to Schrodinger's conference call to review fourth quarter and full year 2025 financial results. My name is Rob and I'll be your operator for today's call. All lines have been placed on
- 8mo agoSDGRSchrödinger Reports Fourth Quarter and Full-Year 2025 Financial ResultsBusiness Wire2025 Total Revenue of $256 Million 2025 Software Revenue of $200 Million; 2025 Software ACV of $198 Million Strong Balance Sheet Supports Path to Positive Adjusted EBITDA by Year-End 2028 Accelerating Transition
- 8mo agoSDGRSchrödinger to Participate in Upcoming Investor ConferencesBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in the following conferences in March: TD Cowen 46th Annual Health Care Conference: Fireside chat on Tuesday, March 3, 2026 at 9:50
- 8mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on February 13, 2026, the company granted (i) non-statutory stock options to purchase 9,600 shares of the company's common stock to two newly hired employees and (ii)
- 9mo agoSDGRSchrödinger to Announce Fourth Quarter and Full-Year 2025 Financial Results on February 25Business WireSchrödinger, Inc. (NASDAQ:SDGR) will report its fourth quarter and full-year 2025 financial results on Wednesday, February 25, 2026, after the financial markets close. The company will host a conference call and webcast
- 9mo agoRXRXTEMSDGRLLYAI-Native Data Core Triggers Multi-Trillion Dollar Healthcare Structural ShiftPR NewswireEquity-Insider.com News Commentary – The global AI medical imaging market exploded to a staggering $2.57 trillion in 2026 as the entire healthcare...
- 10mo agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on December 15, 2025, the company granted restricted stock units (RSUs) with respect to 2,666 shares of the company's common stock to 6 newly hired employees. These
- 11mo agoBEAMCRSPRCKTSDGRBeyond Traditional Drugs: Novel Platforms Targeting Hard-to-Treat ConditionsPR NewswireEquity Insider News Commentary – Traditional pharmaceutical strategies are giving ground as breakthrough approvals for gene therapies and mRNA...
- 1y agoSDGRSchrödinger to Present at Jefferies London Healthcare ConferenceBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00
- 1y agoSDGRSchrödinger Reports Third Quarter 2025 Financial ResultsBusiness WireThird Quarter Total Revenue of $54.3 Million, Software Revenue of $40.9 Million Updates 2025 Financial Guidance Schrödinger, Inc. (NASDAQ:SDGR) today announced financial results for the quarter ended September 30,
- 1y agoSDGRCopernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with SchrödingerBusiness WirePartnership Delivers a Novel, Highly Efficient Ammonia Synthesis Catalyst Companies Begin Work on Improved Ethylene Oxide Catalyst Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with
- 1y agoSDGRSchrödinger to Announce Third Quarter 2025 Financial Results on November 5Business WireSchrödinger (NASDAQ:SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m.
- 1y agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on October 13, 2025, the company granted restricted stock units (RSUs) with respect to 14,888 shares of the company's common stock to 10 newly hired employees. These
- 1y agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on September 14, 2025, the company granted restricted stock units (RSUs) with respect to 1,666 shares of the company's common stock to four newly hired employees.
- 1y agoSDGRSchrödinger, Inc. (SDGR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptEarnings Call Transcripts
- 1y agoSDGRSchrödinger to Present at Morgan Stanley Global Healthcare ConferenceBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced that management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference. The live presentation will take place on Monday,
- 1y agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on August 15, 2025, the company granted restricted stock units (RSUs) with respect to 1,875 shares of the company's common stock to two newly hired employees. These
- 1y agoSDGRSchrödinger Announces Discontinuation of SGR-2921 ProgramBusiness WireSchrödinger, Inc. (NASDAQ:SDGR) today announced the discontinuation of the clinical development program for SGR-2921, its CDC7 inhibitor, which was being evaluated in a Phase 1 dose-escalation study in patients with
- 1y agoSDGRSchrödinger, Inc. (SDGR) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSDGRSchrödinger Reports Second Quarter 2025 Financial ResultsBusiness WireSecond Quarter Total Revenue of $54.8 Million, Software Revenue of $40.5 Million Maintains Full Year 2025 Revenue Growth Guidance and Lowers Operating Expense Guidance Company to Complete Phase 1 Data Package for
- 1y agoSDGRSchrödinger to Announce Second Quarter 2025 Financial Results on August 6Business WireSchrödinger (NASDAQ:SDGR) will report its second quarter 2025 financial results on Wednesday, August 6, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The
- 1y agoSDGRSchrödinger Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)Business WireSchrödinger, Inc. (NASDAQ:SDGR) today reported that on July 14, 2025, the company granted restricted stock units (RSUs) with respect to 3,488 shares of the company's common stock to three newly hired employees. These
- 1y agoSDGRAjax Therapeutics and Schrödinger Expand Research Collaboration to Include Additional JAK TargetBusiness WireAjax Therapeutics, Inc. and Schrödinger, Inc. (NASDAQ:SDGR) today announced an expansion of their exclusive research collaboration to include a new Janus kinase (JAK) target. The partnership was established in 2019 with